Drugs / ClinOleic

Trials 10

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT04051840 Jul 2017 → Jun 2019 — The First Affiliated Hospital with Nanjing Medical University Unknown No outcome recorded
Phase 21 trial
Phase 2 NCT01096771 Jun 2010 → Nov 2012 acute respiratory distress syndrome Methodist Research Institute, Indianapolis Terminated No outcome recorded Stop: Enrollment
Phase 2/32 trials
Phase 2/3 NCT00989339 Nov 2009 → Dec 2011 diabetes mellitus, hypertensive disorder, obesity disorder Emory University Withdrawn No outcome recorded
Phase 2/3 NCT00672854 Nov 2008 → Dec 2010 — Emory University Completed No outcome recorded
Phase 46 trials
Phase 4 NCT03693287 Jul 2021 → Aug 2023 pulmonary immaturity Ospedali Riuniti Ancona Unknown No outcome recorded
Phase 4 NCT04347902 Jan 2016 → Mar 2020 intestinal failure–associated liver disease, liver failure Stanley Dudrick's Memorial Hospital Completed No outcome recorded
Phase 4 NCT01943409 Jul 2013 → Dec 2019 cancer, ileus, protein-energy malnutrition Johane Allard Completed No outcome recorded
Phase 4 NCT01786759 Oct 2012 → May 2013 pulmonary immaturity Shanghai Jiao Tong University School of Medicine Unknown No outcome recorded
Phase 4 NCT01683162 Jul → Dec 2012 pulmonary immaturity Wei Cai Unknown No outcome recorded
Phase 4 NCT03149653 Jan 2012 → Jan 2016 — General University Hospital, Prague Completed No outcome recorded
Comparator or background therapy2 trials
Phase 2/3 NCT02185729 Comparator Jun 2008 → Mar 2012 metabolic disease Emory University Completed No outcome recorded
Phase 3 NCT02760472 Comparator Mar 2013 → Sep 2015 retinopathy of prematurity Carola Pfeiffer-Mosesson Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 12 sources stand behind the page.

FieldValueCited text
Known as ClinOleic “The next morning, after an overnight fast, they will receive, in random order, Intralipid 20%, ClinOleic 20% or normal saline at 20 ml/hr for 24 hr.” NCT00989339 ↗
11

“Intravenous glucose will be "dextrose 50%", amino acids (AA) will be "Primene®" and lipids (FAT) will be "Clinoleic®".” NCT03693287 ↗

“Parenteral nutrition with Olive oil/LCT 80:20 (ClinOleic, Baxter Healthcare, USA, OO group)” NCT04347902 ↗

NCT01683162 ↗

NCT01943409 ↗

NCT00672854 ↗

NCT02185729 ↗

NCT03149653 ↗

NCT04051840 ↗

NCT02760472 ↗

NCT01096771 ↗

Show 1 more source

Modality Other / unclassified “omega-9 "olive-oil" and omega-6 "soybean oil" based lipid emulsions” NCT01096771 ↗
Route Intravenous “ClinOleic 20% Intravenous Emulsion” NCT00672854 ↗